Literature DB >> 13715890

Prednisolone in treatment of pulmonary tuberculosis: a controlled trial. Final report to the Research Committee of the Tuberculosis Society of Scotland.

N W HORNE.   

Abstract

Entities:  

Keywords:  PREDNISOLONE/therapy; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1960        PMID： 13715890      PMCID： PMC2098539          DOI： 10.1136/bmj.2.5215.1751

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  The effects of corticotropin (ACTH) and cortisone in fifteen cases of pulmonary tuberculosis.

Authors:  G S BERG; E J DES AUTELS; J FERSHING; S FREEMAN; J R ZVETINA
Journal:  Dis Chest       Date:  1956-11

2.  Advanced pulmonary tuberculosis with persistent cavitation; preliminary report on prolonged chemotherapy.

Authors:  A C DOUGLAS; N W HORNE
Journal:  Br Med J       Date:  1956-02-18

3.  Cortisone, corticotropin, and antimicrobial therapy in tuberculosis in animals and man; a review.

Authors:  J R JOHNSON; W N DAVEY
Journal:  Am Rev Tuberc       Date:  1954-10

4.  Cortisone in the treatment of pulmonary tuberculosis.

Authors:  J B COCHRAN
Journal:  Edinb Med J       Date:  1954-07
  4 in total
  8 in total

1.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

Authors:  Harriet Mayanja-Kizza; Edward Jones-Lopez; Alphonse Okwera; Robert S Wallis; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  J Infect Dis       Date:  2005-02-08       Impact factor: 5.226

2.  Natural history of segmental lesions in primary pulmonary tuberculosis: long-term review of 383 patients.

Authors:  J B Morrison
Journal:  Arch Dis Child       Date:  1973-02       Impact factor: 3.791

3.  Suppression of prolonged fever during treatment of pulmonary tuberculosis: importance of using twice versus single daily dose of prednisolone.

Authors:  K F Chung; P D Snashall
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

4.  [Purpose, possibilities and limitations of supplementary corticosteroid therapy in lung tuberculosis. Clinical roentgenologic observations].

Authors:  R Ferlinz
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1965-05-31

Review 5.  Novel adjunctive therapies for the treatment of tuberculosis.

Authors:  A A Ordonez; M Maiga; S Gupta; E A Weinstein; W R Bishai; S K Jain
Journal:  Curr Mol Med       Date:  2014-03       Impact factor: 2.222

6.  The MRC randomized trial of streptomycin and its legacy: a view from the clinical front line.

Authors:  J Crofton
Journal:  J R Soc Med       Date:  2006-10       Impact factor: 18.000

7.  Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.

Authors:  Mi-Sun Koo; Claudia Manca; Guibin Yang; Paul O'Brien; Nackmoon Sung; Liana Tsenova; Selvakumar Subbian; Dorothy Fallows; George Muller; Sabine Ehrt; Gilla Kaplan
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

8.  Corticosteroid effects on sputum culture in pulmonary tuberculosis: a meta-regression analysis.

Authors:  Robert S Wallis
Journal:  Open Forum Infect Dis       Date:  2014-06-03       Impact factor: 3.835
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.